Literature DB >> 10309325

Medicare program; solicitation of hospitals and medical centers to participate in a study of heart transplants: Health Care Financing Administration. Notice.

.   

Abstract

This notice invites hospitals and medical centers to participate in a study of heart transplants to be conducted by HCFA. The purpose of the study is to examine, in general, all aspects of heart transplants, including the scientific, social, economic, and ethical issues, and, in particular, the impact of a possible Medicare decision to pay for heart transplants on the Medicare program, Medicare beneficiaries, and providers of health care. The study will be done in two related parts--the selection and participation of hospitals and medical centers, to which this notice is addressed, and an analysis of pertinent data and issues, to be conducted by an independent contractor. Hospitals and medical centers selected to participate in this study, under this notice, may be reimbursed for a limited number of heart transplants performed for Medicare beneficiaries during the course of the study. In addition, these institutions will furnish data about heart transplants performed at their facilities and will be reimbursed for the costs of furnishing this information. This notice contains information about the study, the availability of funds, and the procedures by which interested institutions can communicate their willingness to participate in the study. This notice also contains the criteria for the selection of hospitals and medical centers for heart transplant funding.

Keywords:  Health Care Financing Administration; Health Care and Public Health; National Heart Transplantation Study

Mesh:

Year:  1981        PMID: 10309325

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  1 in total

1.  Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.

Authors:  Daniel P Mulloy; Castigliano M Bhamidipati; Matthew L Stone; Gorav Ailawadi; Irving L Kron; John A Kern
Journal:  J Thorac Cardiovasc Surg       Date:  2012-12-13       Impact factor: 5.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.